FDA Clears Avastin for Breast Cancer

(AP) -- A Genentech drug received federal approval on Friday to treat breast cancer, a surprise decision that could represent a shift in standards for assessing the effectiveness of cancer medicines.

If you want to include this story in your blog, copy and paste this formatted text: